4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000076
EVP, Chief Development Officer sold 1,406 shares at $32.40 ($45,561)
- EVP, Chief Development Officer acquired 3,820 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Geary Richard S · EVP, Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-30 | Grant or award : show line 1 in the form | +3,820 | 100,483 | D | ||
| 2025-01-31 | Sale : show line 2 in the form | −1,406 | $32.40 | $45,561 | 99,077 | D |
| Open-market sales · 1,406 sh · avg $32.40 · $45,561 | ||||||
Loading xslF345X05/edgardoc.xml…